Device-identified atrial fibrillation at pacing clinics. Should it guide anticoagulation?

被引：6

作者：

Merinopoulos, Ioannis ^{[1
]}

Raphael, Claire E. ^{[2
,3
,4
]}

Yardley, Alaina ^{[5
]}

Goonewardene, Manoj ^{[1
]}

Vassiliou, Vassilios S. ^{[2
,3
]}

机构：

[1] Papworth Hosp, Dept Cardiol, Cambridge CB3 8RE, England

[2] Royal Brompton & Harefield NHS Trust, Dept Cardiol, London & Biomed Res Unit, Royal Brompton Hosp, London, England

[3] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England

[4] Mayo Clin, Dept Cardiol, 200 First St SW, Rochester, MN 55905 USA

[5] Papworth Hosp, Dept Cardiac Physiol, Cambridge CB3 8RE, England

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 207卷

关键词：

Pacemaker; Implanted device; Atrial fibrillation; Anticoagulation; Stroke; Thromboembolic risk; TEMPORAL RELATIONSHIP; FOLLOW-UP; STROKE; RISK; INFORMATION; PREVALENCE; MANAGEMENT; PACEMAKERS; FEATURES;

D O I：

10.1016/j.ijcard.2016.01.040

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In recent years, there has been a significant increase in the number of devices implanted following improvement in their safety profile, extension of indications and reduction in cost. Although the reason remains largely the beneficial effect on heart rhythm stabilisation, implanted devices might also have additional advantages, notably identification of silent arrhythmia. Should clinicians therefore act on device-identified atrial fibrillation (AF) and should such identification be used to guide anticoagulation management? This review evaluates the current evidence on the management of device-identified asymptomatic AF. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

引用

页码：378 / 381

页数：4

共 31 条

[1] The Clinical Profile and Pathophysiology of Atrial Fibrillation Relationships Among Clinical Features, Epidemiology, and Mechanisms [J].

Andrade, Jason ;

Khairy, Paul ;

Dobrev, Dobromir ;

Nattel, Stanley .

CIRCULATION RESEARCH, 2014, 114 (09) :1453-1468

[2]

[Anonymous], APIXABAN REDUCTION T

[3]

[Anonymous], NONVITAMIN K ANTAGON

[4]

[Anonymous], SILENT SUBCLINICAL A

[5]

[Anonymous], HEART RHYTHM SOC SCI

[6]

[Anonymous], MUCH ATRIAL FIBRILLA

[7] Comparison of Rate Versus Rhythm Control in Patients With Atrial Fibrillation and a Pacemaker [J].

Badheka, Apurva Omkar ;

Marzouka, George Robert ;

Rathod, Ankit Dineshbhai ;

Patel, Nileshkumar Jasmatbhai ;

Myerburg, Robert Jerome ;

Mitrani, Raul David .

AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (12) :1759-1763

[8] AF detected on implanted cardiac implantable electronic devices: Is there a threshold for thromboembolic risk? topical collection on arrhythmia [J].

Baibars M. ;

Kanjwal K. ;

Marine J.E. .

Current Treatment Options in Cardiovascular Medicine, 2014, 16 (3)

[9] Device-detected atrial fibrillation and risk for stroke: an analysis of > 10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) [J].

Boriani, Giuseppe ;

Glotzer, Taya V. ;

Santini, Massimo ;

West, Teena M. ;

De Melis, Mirko ;

Sepsi, Milan ;

Gasparini, Maurizio ;

Lewalter, Thorsten ;

Camm, John A. ;

Singer, Daniel E. .

EUROPEAN HEART JOURNAL, 2014, 35 (08) :508-516

[10] Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events [J].

Botto, Giovanni L. ;

Padeletti, Luigi ;

Santini, Massimo ;

Capucci, Alessandro ;

Gulizia, Michele ;

Zolezzi, Francesco ;

Favale, Stefano ;

Molon, Giulio ;

Ricci, Renato ;

Biffi, Mauro ;

Russo, Giovanni ;

Vimercati, Marco ;

Corbucci, Giorgio ;

Boriani, Giuseppe .

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 (03) :241-248

← 1 2 3 4 →